Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01)

The summary for the Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01): This limited competition Funding Opportunity Announcement (FOA) invites a cooperative agreement (U01) application from projects funded within the Collaboration on Fetal alcohol Spectrum Disorders (FASD) Prevalence (CoFASP). The purpose of this limited competition is to allow additional follow-up for the development and use of a standardized diagnostic system to evaluate clinical characteristics of FASD among affected children and establish prevalence rates.This FOA supports continuation of the Collaboration on FASD Prevalence (CoFASP).
Federal Grant Title: Limited Competition for the Continuation of CoFASP (Collaboration on Fetal alcohol Spectrum Disorders Prevalence) Diagnostic Classifications (Collaborative U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-AA-16-007
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.273
CFDA Descriptions: Alcohol Research Programs
Current Application Deadline: Apr 10, 2016
Original Application Deadline: Apr 10, 2016
Posted Date: Jan 28, 2016
Creation Date: Jan 28, 2016
Archive Date: May 11, 2016
Total Program Funding: $750,000
Maximum Federal Grant Award: $250,000
Minimum Federal Grant Award: none
Expected Number of Awards: 2
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Private institutions of higher education
Public and State controlled institutions of higher education
Additional Information on Eligibility
Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Link to Full Grant Announcement
http://grants.nih.gov/grants/guide/rfa-files/RFA-AA-16-007.html
Grant Announcement Contact
NIH OER Webmaster FBOWebmaster@OD.NIH.GOV
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster

National Institutes of Health 301-496-3405
Similar Government Grants
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia (U01 Clinical Trial Opt...
Health Services Research on Minority Health and Health Disparities (R01- Clinical Trial Op...
Device-Based Treatments for Substance Use Disorders (UG3/UH3, Clinical Trial Optional)
Mechanisms of Alcoholic Pancreatitis
Alcohol Abuse and Hiv/Aids in Resource-Poor Societies
Mechanisms of Alcohol-Induced Tissue Injury
More Grants from the National Institutes of Health
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Administrative Resource...
Integrative Neuroscience Initiative on Alcoholism (INIA) Consortia Research Resource (U24)...
New Cohorts for Environmental Exposures and Cancer Risk (CEECR; UG3/UH3 Clinical Trial Not...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical ...
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Tria...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2021 FederalGrants.com